Opening book details…
Can I read Dipeptidyl peptidase-4 inhibitors: Anti-diabetic drugs with potential effects on cancer on EtoBox?
Dipeptidyl peptidase-4 inhibitors: Anti-diabetic drugs with potential effects on cancer by Alaa G. Almagthali; Eman H. Alkhaldi; Afnan S. Alzahrani; Ameera K. Alghamdi; Waleed Y. Alghamdi; Ahmed M. Kabel is a Medicine article available to read on EtoBox.
What is Dipeptidyl peptidase-4 inhibitors: Anti-diabetic drugs with potential effects on cancer about?
Dipeptidyl peptidase (DPP- 4) inhibitors belong to the oral antidiabetic drugs. They are used for the treatment of Type 2 Diabetes mellitus. DPP-4 is an enzyme which puts down the action of hormone, incretin. Incretins belong to the group of hypoglycaemic gastrointestinal hormones. Some studies show that DPP-4 inhibitors causes cancer and some study show that they have anticancer property. This review sheds light on the role of the different types of DPP-4 inhibitors in cancer therapy.
Who reads Dipeptidyl peptidase-4 inhibitors: Anti-diabetic drugs with potential effects on cancer?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Alaa G. Almagthali; Eman H. Alkhaldi; Afnan S. Alzahrani; Ameera K. Alghamdi; Waleed Y. Alghamdi; Ahmed M. Kabel
- Published
- 2019
- Language
- EN
- Field
- Medicine (Health Sciences)